Should the FDA approval process for weight-loss drugs be modified?
- PMID: 22011989
- DOI: 10.2146/ajhp110228
Should the FDA approval process for weight-loss drugs be modified?
Comment on
-
Lorcaserin: an investigational serotonin 2C agonist for weight loss.Am J Health Syst Pharm. 2011 Nov 1;68(21):2029-37. doi: 10.2146/ajhp100638. Am J Health Syst Pharm. 2011. PMID: 22011982 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
